Overview
- 22 inspections across 22 sites are on record.
- 15 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2023-01-27.
At a glance
Inspections
22
Sites
22
Observations
15
Career since
Feb 2020
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| ECI Pharmaceuticals LLC | 27 Jan 2023 | Human Drugs | View 483 → |
| Jaynier Moya, M.D. | 23 Dec 2022 | Biologics | |
| GILBERTO JIMENEZ M.D. | 21 Nov 2022 | Human Drugs | |
| Joely Kaufman-Janette, M.D. | 12 Oct 2022 | Medical Devices & Rad Health | |
| Yanetsi Flores Landa, M.D. | 16 Sep 2022 | Human Drugs | View 483 → |
Sites inspected
ECI Pharmaceuticals LLCFt Lauderdale, United States1 insp.
Jaynier Moya, M.D.Pembroke Pines, United States1 insp.
GILBERTO JIMENEZ M.D.Miami, United States1 insp.
Joely Kaufman-Janette, M.D.Coral Gables, United States1 insp.
Yanetsi Flores Landa, M.D.North Lauderdale, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Richard A Lyght5 shared
Angelica M Chica3 shared
Emily A Baldwin1 shared
Emily A Green1 shared
Ana P Barido1 shared
Laura L Staples1 shared
Jonathan R Campos1 shared
Sheri L Stephenson1 shared
Full investigator report
Get the verbatim findings behind Matthew F Duff's 15 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site